Skip to main content
    I

    IDEXX Laboratories Inc (IDXX)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $547.18
    +18.17 (+3.43%)

    Market Cap: $40.99B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    97%(38/39)
    Avg Surprise
    +10.27%
    Streak
    16 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$3.70
    Range$3.37 - $3.91
    11 analysts
    EPS Revisions
    2
    0
    7d
    3
    7
    30d
    EPS Estimate DriftChange to current
    90d ago$3.78-2.1%
    60d ago$3.71-0.1%
    30d ago$3.71-0.1%
    7d ago$3.700.0%
    Current$3.70
    Revenue Consensus
    $1.2B
    Range$1.2B - $1.2B
    10 analysts
    Period ending Dec 31, 2026
    EPS Consensus$3.78
    Range$3.41 - $4.13
    12 analysts
    Revenue Consensus
    $1.2B
    Range$1.2B - $1.2B
    12 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$3.78---
    Sep 26EST
    		-$3.70---
    Jun 26
    Reported Aug 4
    		$4.27$3.95+8.10%Beat+17.6%
    Mar 26
    Reported May 5
    		$3.47$3.41+1.76%Beat+17.2%
    Dec 25
    Reported Feb 2
    		$3.08$2.94+4.76%Beat+17.6%
    Sep 25
    Reported Nov 3
    		$3.40$3.15+7.94%Beat+21.4%
    Jun 25
    Reported Aug 4
    		$3.63$3.30+10.00%Beat+20.2%
    Mar 25
    Reported May 1
    		$2.96$2.84+4.23%Beat+5.3%
    Dec 24
    Reported Feb 3
    		$2.62$2.40+9.17%Beat+12.9%
    Sep 24
    Reported Oct 31
    		$2.80$2.69+4.09%Beat+10.7%
    Jun 24
    Reported Aug 6
    		$3.02$2.87+5.23%Beat+13.1%
    Mar 24
    Reported May 1
    		$2.81$2.67+5.24%Beat+10.2%
    Dec 23
    Reported Feb 5
    		$2.32$2.12+9.43%Beat+13.2%
    Sep 23
    Reported Nov 1
    		$2.53$2.37+6.75%Beat+17.7%
    Jun 23
    Reported Aug 1
    		$2.67$2.47+8.10%Beat+71.2%
    Mar 23
    Reported May 2
    		$2.55$2.43+4.94%Beat+12.3%
    Dec 22
    Reported Feb 6
    		$2.05$1.92+6.77%Beat+8.5%
    Sep 22
    Reported Nov 1
    		$2.15$2.04+5.39%Beat+5.9%
    Jun 22
    Reported Aug 2
    		$1.56$1.63-4.29%Miss-33.3%
    Mar 22
    Reported May 4
    		$2.27$2.25+0.89%Beat-3.4%
    Dec 21
    Reported Feb 2
    		$1.89$1.72+9.88%Beat+7.4%
    Sep 21
    Reported Nov 2
    		$2.03$1.91+6.28%Beat+20.1%
    Jun 21
    Reported Jul 30
    		$2.34$2.04+14.71%Beat+36.0%
    Mar 21
    Reported May 4
    		$2.35$1.72+36.63%Beat+82.2%
    Dec 20
    Reported Feb 2
    		$1.76$1.39+26.62%Beat+69.2%
    Sep 20
    Reported Oct 29
    		$1.69$1.44+17.36%Beat+36.3%
    Jun 20
    Reported Jul 31
    		$1.72$1.17+47.01%Beat+20.3%
    Mar 20
    Reported Apr 30
    		$1.29$1.20+7.50%Beat+10.3%
    Dec 19
    Reported Jan 31
    		$1.04$0.90+15.56%Beat+6.1%
    Sep 19
    Reported Oct 31
    		$1.24$1.14+8.77%Beat+18.1%
    Jun 19
    Reported Aug 1
    		$1.43$1.37+4.38%Beat+16.3%
    Mar 19
    Reported May 1
    		$1.17$1.06+10.38%Beat+15.8%
    Dec 18
    Reported Feb 1
    		$0.98$0.91+7.69%Beat+27.3%
    Sep 18
    Reported Nov 1
    		$1.05$0.97+8.25%Beat+32.9%
    Jun 18
    Reported Aug 1
    		$1.23$1.17+5.13%Beat+29.5%
    Mar 18
    Reported May 4
    		$1.01$0.92+9.78%Beat+31.2%
    Dec 17
    Reported Feb 1
    		$0.77$0.73+5.48%Beat+32.8%
    Sep 17
    Reported Oct 31
    		$0.79$0.74+6.76%Beat-
    Jun 17
    Reported Aug 1
    		$0.95$0.85+11.76%Beat-
    Mar 17
    Reported Apr 28
    		$0.77$0.60+28.33%Beat-
    Dec 16
    Reported Feb 2
    		$0.58$0.51+13.73%Beat-

    Key Metrics

    Valuation
    P/E Ratio38.48EV/EBITDA27.27x
    Price/FCF34.44xFCF Yield2.90%
    Profitability
    Profit Margin25.00%Operating Margin35.00%
    ROE74.20%ROIC45.21%
    Financial Health
    Debt/Equity0.60xInterest Coverage38.60x
    Current Ratio1.17xQuick Ratio0.87x
    Trading Statistics
    Beta1.55Avg Volume521.21K
    52-Week High$769.9852-Week Low$500.61

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$521.91
    SMA 20$521.23
    SMA 50$535.84
    SMA 200$580.28
    EMA 10$525.55
    EMA 20$523.99
    EMA 50$532.17
    EMA 200$563.57

    MACD

    Line: -0.41Signal: -3.88Hist: 3.47

    ADX

    ADX: 13.8+DI: 27.4-DI: 14.4

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down4.0
    PSAR$502.83

    Bollinger Bands

    Upper Band$539.14
    Lower Band$503.33
    %B Position687%(Upper)
    Band Width1.22

    RSI (14-Day)

    Neutral
    61.3

    Momentum Oscillators

    Stoch %K76.8
    Stoch %D65.6
    Williams %R-1.4
    ROC (10d)5.7%
    Momentum29.43
    CCI (20d)290.9
    MFI (14d)63.2

    Volatility Measures

    ATR (14d)$13.04(2.4%)
    StdDev (20d)8.95
    Hist Vol23.8%(Moderate)

    Volume Flow

    VWAP$543.43
    OBV19.4M
    AD Line11.8M
    CMF (20d)0.259

    Volume Metrics

    Avg Vol (20d)531.5K
    Vol Ratio1.0x
    VWMA (20d)$521.00

    Pivot Points

    R3$543.61
    R2$536.62
    R1$532.82
    Pivot Point$525.83
    S1$522.02
    S2$515.03
    S3$511.23

    Advanced Oscillators

    TSI-1.20
    Ultimate Osc64.7
    KST-13.54

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.22B$1.14B$1.09B$1.11B$1.11B$998.43M$954.29M$975.54M$1.00B$964.10M$901.60M$915.53M
    Cost of Revenue$437.50M$418.08M$432.46M$421.88M$414.73M$375.05M$383.63M$379.50M$384.42M$371.02M$375.43M$367.55M
    Gross Profit$779.09M$722.74M$658.11M$683.35M$694.73M$623.38M$570.66M$596.04M$619.16M$593.07M$526.17M$547.98M
    Operating Expenses$353.52M$360.15M$342.51M$328.51M$321.69M$306.85M$308.97M$292.15M$355.36M$294.11M$280.87M$272.70M
    R&D$65.43M$65.79M$66.83M$63.41M$61.90M$59.06M$57.73M$53.98M$55.45M$52.63M$51.81M$47.97M
    SG&A$116.81M$119.11M$108.62M$105.94M$98.68M$91.56M$101.14M$91.89M$157.24M$92.02M$87.02M$89.03M
    Operating Income$425.57M$362.59M$315.61M$354.85M$373.05M$316.53M$261.69M$303.89M$263.80M$298.96M$245.30M$275.28M
    Interest Income$1.84M$597,000$587,000$580,000$627,000$1.22M$2.20M$2.71M$3.35M$4.43M$3.63M$1.25M
    Interest Expense$10.18M$7.74M$9.21M$10.65M$11.32M$7.67M$7.50M$7.70M$8.10M$7.91M$9.27M$8.65M
    Income Before Tax$417.22M$355.44M$306.98M$344.77M$362.35M$310.08M$256.39M$298.91M$259.06M$295.48M$239.67M$267.89M
    Income Tax Expense$78.81M$77.00M$58.79M$70.16M$68.36M$67.41M$40.24M$66.07M$55.76M$59.90M$45.15M$55.66M
    Net Income$338.41M$278.45M$248.19M$274.61M$293.99M$242.68M$216.15M$232.84M$203.30M$235.58M$194.52M$212.23M
    EBITDA$466.62M$400.27M$354.33M$391.47M$408.82M$350.60M$295.39M$338.02M$295.99M$328.86M$275.04M$304.27M
    EBIT$425.57M$362.59M$315.61M$354.85M$373.05M$316.53M$261.69M$303.89M$263.80M$298.96M$245.30M$275.28M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IDXX

    Government Contracts

    Gov Obligations (TTM)
    $2.07M
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    22.3%
    Active Awards
    96
    New Awards (TTM)
    51
    Avg Remaining Term
    8.4 mo

    Top agency: Department of Health and Human Services at 67.2% of trailing twelve month obligations across 5 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    75N98026F00001Department of Health and Human ServicesNational Institutes of Health$594443Jul 1, 2026
    75N98026F00002Department of Health and Human ServicesNational Institutes of Health$390000Apr 10, 2026
    75N98026F00001Department of Health and Human ServicesNational Institutes of Health$230000Oct 1, 2025
    75N98025F00010Department of Health and Human ServicesNational Institutes of Health$185000May 1, 2025
    12639526F0321Department of AgricultureAnimal and Plant Health Inspection Service$153367Mar 17, 2026
    1232SA25P0452Department of AgricultureAgricultural Research Service$110800Sep 22, 2025
    N0010426PBH04Department of DefenseDepartment of the Navy$102840Jan 28, 2026
    12639526F0497Department of AgricultureAnimal and Plant Health Inspection Service$92883May 5, 2026
    W81K0025PA184Department of DefenseDepartment of the Army$56515Sep 4, 2025
    12639525F0957Department of AgricultureAnimal and Plant Health Inspection Service$27700Aug 22, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    IDEXX Laboratories, Inc. (IDXX) Stock forecasts

    Argus has raised its target price for IDEXX Laboratories, Inc. (IDXX) stock to $572.00, noting that the company primarily develops, manufactures, and distributes diagnostic products, equipment...

    Yahoo Finance Australia•10/16/26•Neutral

    IDEXX Laboratories stock sits 36.51 percent below USD 747.00 target

    IDEXX Laboratories (IDXX) stock is currently trading 36.51% below its average 12-month analyst target of USD 747.00. The company's third-quarter 2026 results are scheduled for release on November 2, 2026...

    ad-hoc-news.de•10/15/26•Neutral

    IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors despite daily gains

    IDEXX Laboratories Inc. (IDXX) stock rose 1.67% on Wednesday to $529.01, despite a general downturn in the stock market. However, the stock still underperformed compared to its competitors...

    MarketWatch•10/14/26•Somewhat-Bearish

    IDEXX Laboratories (IDXX) Stock Forecast and Price Target 2026

    IDEXX Laboratories (IDXX) has a "Moderate Buy" consensus rating from 11 Wall Street analysts, with an average price target of $747.00...

    MarketBeat•10/12/26•Bullish

    Old Dominion Freight Line, Inc. (ODFL) Stock Forecasts

    Argus Research published a report on Old Dominion Freight Line, Inc. (ODFL) on October 12, 2026, indicating that a volume inflection is nearing for the company. Old Dominion Freight Line is a leading less-than-truckload...

    Yahoo! Finance Canada•10/12/26•Somewhat-Bearish

    IDXX Valuation and Fair Value

    P/E
    38.5x
    Forward P/E
    31.4x
    EV/EBITDA
    27.3x
    P/FCF
    34.4x
    PEG
    2.9x
    P/B
    26.8x
    See GNG's fair value

    IDXX Profitability: Margins, ROIC and FCF

    Gross margin
    62.4%
    Operating margin
    35.0%
    Net margin
    25.0%
    ROIC
    45.2%
    ROE
    74.2%
    FCF margin
    27.5%
    FCF yield
    2.9%

    IDXX Competitors

    CompanyTicker
    Illumina IncILMN
    BeiGene, Ltd.ONC
    Revolution Medicines IncRVMD
    Centene CorpCNC
    Haleon plcHLN
    Biogen IncBIIB
    Waters CorporationWAT
    Royalty Pharma PlcRPRX

    Sector: Healthcare

    IDXX Analyst Ratings

    Consensus
    Buy
    Analysts
    13
    Strong Buy
    4
    Buy
    4
    Hold
    4
    Sell
    0
    Strong Sell
    1

    IDXX Bull Case vs Bear Case

    Bull case

    • IDXX earns a 45.2% return on invested capital.
    • IDXX converts 27.5% of revenue into free cash flow.
    • IDXX has a 25.0% net profit margin.

    IDXX Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    6.3%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $3.70
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    3 up, 7 down

    Frequently Asked Questions About IDXX

    Does IDXX pay dividends?

    IDEXX Laboratories Inc (IDXX) does not currently pay a regular dividend.

    What is IDXX's P/E ratio?

    IDEXX Laboratories Inc has a price-to-earnings (P/E) ratio of 38.48.

    What is IDXX's market cap?

    IDEXX Laboratories Inc (IDXX) has a market capitalization of $40.99B with a current stock price of $547.18.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In